A group of 118 leading cancer experts have developed a list of proposals designed to reduce the cost of cancer drugs. Also in support of a grassroots patient protest movement to pressure drug companies to charge what they deem a fair value for treatments. Experts include former presidents of the American Society of Clinical Oncology and the American Society of Hematology. An insured cancer patient who needs a drug that costs $120,000 a year would pay as much as $30,000 in out-of-pocket costs, which is more than half of the average U.S. household income of $52,000.
Read More